Compare PRGO & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRGO | EFC |
|---|---|---|
| Founded | 1887 | 2007 |
| Country | Ireland | United States |
| Employees | N/A | 500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2013 | N/A |
| Metric | PRGO | EFC |
|---|---|---|
| Price | $12.27 | $13.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $19.33 | $14.55 |
| AVG Volume (30 Days) | ★ 2.2M | 1.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | 10.28% | ★ 11.84% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.02 | $43.05 |
| P/E Ratio | ★ N/A | $9.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.23 | $11.28 |
| 52 Week High | $28.44 | $14.12 |
| Indicator | PRGO | EFC |
|---|---|---|
| Relative Strength Index (RSI) | 61.66 | 68.80 |
| Support Level | $12.17 | $13.25 |
| Resistance Level | $15.08 | $14.00 |
| Average True Range (ATR) | 0.47 | 0.20 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 76.52 | 86.78 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. It acquires reverse mortgage loans both through its origination activities and through secondary market purchases.